Transparency Market Research
Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Published Date 12-March-2014
102 Page Report
Buy Now
Request Sample
Press Release Multiplexed Diagnostics Market in 2019: Transparency Market Research
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
REPORT DESCRIPTION
Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR, bead-based and microplate assays and next-generation sequencing. Further this market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer’s disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures by reducing the turnaround time and analyzing multiple analytes in a single cycle and thereby resulting in rapid adoption of such techniques. The stake holders in this market include market players who provide multiplexed diagnostic assay kits, reagents, solutions and systems. Browse the Multiplexed Diagnostics Market Research Report at http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html This research report provides a detailed analysis of the global multiplexed diagnostics market and also covers the various driving factors which are responsible for the growth of this market. The executive summary comprises the market snapshot which gives details about various segments and sub-segments, and also includes the comparative analysis of the multiplexed diagnostics market according to its segmentation. The qualitative details of the market dynamics of the multiplexed diagnostics market such as drivers, restraints and opportunities that influence the current nature and future status of this field are covered under the market overview section of this report. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market. All these factors would help the market players to gain thorough analysis of the overall competitive scenario and thereby decide upon the business strategies and plans to be incurred in future for sustaining and growing in the global multiplexed diagnostics market. Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1719 The global multiplexed diagnostics market is classified based on the types of technology, application and geography. The market size and estimates from 2011 to 2019 for each of these segments is provided in USD million in this report. The multiplexed diagnostics market based on the type of technology is segmented into very high density multiplexed assays, high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays, and next generation sequencing assays. Furthermore, based on the type of applications, the market is characterized into infectious disease diagnosis, oncology, autoimmune disease, cardiac, allergies and others. A detailed market analysis of the above segments has been provided in this study, based on their market size and forecast in terms of USD million for the period 2011 to 2019. The compounded annual growth rate (CAGR %) has been estimated for the period 2013 to 2019, considering 2012 as the base year.
Browse More Medical Devices Related Research Report at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html In terms of geographical distribution, the global multiplexed diagnostics market has been categorized into four geographical regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). This section further includes the market size and forecast of the mentioned regional markets for the period 2011 to 2019 along with their growth rates. This report also includes strategic recommendations, which would be useful for the current and future market players to sustain, grow and establish position in the global multiplexed diagnostics market. This report concludes with the company profiles section which comprises key information such as company overview, financial overview, product portfolio, business strategies, and recent developments about the major players in multiplexed diagnostics market. Some of the key players profiled in this report include Affymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Life Technologies, Luminex Corporation and Illumina, Inc.
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation: Multiplexed Diagnostics Market 1.4 List of Abbreviations
Chapter 2 Executive Summary
Chapter 3 Multiplexed Diagnostics Market Overview 3.1 Overview – Current Market Scenario and Future Market Trends 3.1.1 Global Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million) 3.2 Market Dynamics 3.2.1 Market Drivers 3.2.2 Completion of the Human Genome Project 3.2.3 Increasing Prevalence of Cancer and Infectious Diseases
3.2.4 Multiple Usage 3.2.5 Evolving Regulatory landscape 3.3 Restraints 3.3.1 Costly Equipment 3.3.2 Lack of Skilled Labour 3.3.3 Lack of Reimbursement Coverage 3.4 Opportunities 3.4.1 Automation of the Multiplexed Diagnostic Instrument 3.4.2 Development Of Generic Platform
Browse the Multiplexed Diagnostics Market Research Report at http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html
3.5 Porter’s Five Force Analysis: Global Multiplexed Diagnostics Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of New Entrants 3.5.4 Threat of Substitutes 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis of Multiplexed Assay Market, by Geography
Chapter 4 Global Multiplex Assays Market, by Technology 4.1 Overview – Current Market Scenario and Future Market Trends 4.2 Comparative Analysis: Global Multiplexed Diagnostics Market, by Technology (Value %) 4.3 Very High Density Multiplexed Assays (> 10,000-plex)
4.3.1 Global Very High Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million) 4.3.2 Oligonucleotide Arrays 4.3.3 Phage Display 4.4 High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) 4.4.1 Global High Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million) 4.4.2 Bacterial Artificial Chromosome Arrays 4.4.3 Protein Arrays 4.5 Medium Density Multiplexed Assays (plex < 500) 4.5.1 Global Medium Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million) 4.5.2 Bead-based Arrays 4.5.3 Antibody Arrays 4.5.4 Reverse Arrays 4.5.5 Mass Spectrometry 4.6 Low Density Multiplexed Assays (plex ≤ 5) 4.6.1 Global Low Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million) 4.6.2 Quantitative PCR 4.6.3 Microplate Assays 4.7 Next Generation Sequencing Assays 4.7.1 Global Next Generation Sequencing Market Revenue, 2011 – 2019, (USD Million)
Browse the Multiplexed Diagnostics Market Research Report at http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html
Chapter 5 Global Multiplex Diagnostics Market, By Application
5.1 Overview – Current Market Scenario and Future Market Trends 5.1.1 Comparative Analysis: Global Multiplexed Diagnostics Market, by Application (Value %) 5.1.2 Infectious Disease Diagnosis 5.1.3 Global Multiplexed Infectious Disease Diagnostics Market Revenue, 2011 – 2019, (USD Million) 5.1.4 Oncology 5.1.5 Global Multiplexed Oncology Diagnostics Market Revenue, 2011 – 2019, (USD Million) 5.1.6 Autoimmune diseases 5.1.7 Global Multiplexed Autoimmune Disease Diagnostics Market Revenue, 2011 – 2019, (USD Million) 5.1.8 Cardiac 5.1.9 Global Multiplexed Cardiac Diagnostics Market Revenue, 2011 – 2019, (USD Million) 5.1.10 Allergies 5.1.11 Global Multiplexed Allergy Diagnostics Market Revenue, 2011 – 2019, (USD Million) 5.1.12 Others 5.1.13 Global Other Multiplexed Diagnostic Applications Market Revenue, 2011 – 2019, (USD Million)
Chapter 6 Global Multiplexed Diagnostics Market, by Geography 6.1 Introduction 6.1.1 Comparative Analysis: Global Multiplexed Diagnostics Market, by Geography (Value %) 6.2 North America 6.2.1 North America Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million) 6.3 Europe 6.3.1 Europe Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million) 6.4 Asia-Pacific
6.4.1 Asia-Pacific Multiplexed Diagnostics Market Revenue, 2011 â&#x20AC;&#x201C; 2019 (USD Million) 6.5 Rest of the World (RoW) 6.5.1 Rest of the World (RoW) Multiplexed Diagnostics Market Revenue, 2011 â&#x20AC;&#x201C; 2019 (USD Million)
Chapter 7 Company Profiles 7.1 Affymetrix, Inc. 7.1.1 Company Overview 7.1.2 Financial Overview 7.1.3 Product Portfolio 7.1.4 Business Strategies 7.1.5 Recent Developments
Browse the Multiplexed Diagnostics Market Research Report at http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html
7.2 Agilent Technologies, Inc. 7.2.1 Company Overview 7.2.2 Financial Overview 7.2.3 Product Portfolio 7.2.4 Business Strategies 7.2.5 Recent Developments 7.3 bioMerieux, Inc. 7.3.1 Company Overview 7.3.2 Financial Overview
7.3.3 Product Portfolio 7.3.4 Business Strategies 7.3.5 Recent Developments 7.4 Bio-Rad Laboratories, Inc. 7.4.1 Company Overview 7.4.2 Financial Overview 7.4.3 Product Portfolio 7.4.4 Business Strategies 7.4.5 Recent Developments 7.5 Illumina, Inc. 7.5.1 Company Overview 7.5.2 Financial Overview 7.5.3 Product Portfolio 7.5.4 Business Strategies 7.5.5 Recent Developments 7.6 F. Hoffman-La Roche, Ltd. 7.6.1 Company Overview 7.6.2 Financial Overview 7.6.3 Product Portfolio 7.6.4 Business Strategies 7.6.5 Recent Developments 7.7 Gen-Probe, Inc. 7.7.1 Company Overview 7.7.2 Financial Overview 7.7.3 Product Portfolio
7.7.4 Business Strategies 7.7.5 Recent Developments 7.8 Life Technologies Corporation 7.8.1 Company Overview 7.8.2 Financial Overview 7.8.3 Business Strategies 7.8.4 Recent Developments
Browse the Multiplexed Diagnostics Market Research Report at http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html
7.9 Luminex Corporation 7.9.1 Company Overview 7.9.2 Financial Overview 7.9.3 Product Portfolio 7.9.4 Business Strategies 7.9.5 Recent Developments 7.10 Seegene, Inc. 7.10.1 Company Overview 7.10.2 Financial Overview 7.10.3 Product Portfolio 7.10.4 Business Strategies 7.10.5 Recent Developments About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com/